At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting SteNt Study: Head-to-head Comparison of Clinical Outcome After Implantation of Second Generation Drug-eluting Stents in a Real World Scenario
In Brief
A Phase 4 clinical trial evaluating Endeavor Resolute (Biolinx-based Zotarolimus-eluting stent) and Xience V (Everolimus-eluting stent) for Coronary Artery Disease and 4 related conditions. Completed, enrolled 1,391 participants across 1 site.
Detailed Summary
The TWENTE Study is a single center prospective single-blinded randomized study. Randomization will involve the type of Drug-Eluting Stent (DES) used in study population. Patients will be blinded to the type of DES they will receive. The general practitioner of the patient will be requested not to disclose this information to the patient. Analysts who perform the data analyses will be blinded to the type DES used as well.
Study Details
Timeline
Interventions
Drug eluting Stent
Drug eluting stent